Skip to main content
Top
Published in: Abdominal Radiology 5/2008

01-09-2008

Complete penile corporeal septation: evaluation with contrast enhanced US

Authors: Michele Bertolotto, Stefano Bucci, Emilio Quaia, Matteo Coss, Giovanni Liguori

Published in: Abdominal Radiology | Issue 5/2008

Login to get access

Abstract

Background

Complete penile corporeal septation is a rare malformation in which the corpora cavernosa are completely isolated. We describe a new method to reach the diagnosis of this malformation using contrast enhanced US.

Methods

Two patients with complete penile corporeal septation underwent color Doppler and contrast enhanced US after bilateral cavernosal injection of 10 μg prostaglandin E1. Contrast enhanced US was performed using a contrast specific software (Contrast-Tuned imaging, EsaOte, Genoa, Italy) and a linear transducer designed to evaluate superficial structures. Microbubbles of SonoVue (Bracco, Milan, Italy) were injected in one corpus cavernosum.

Results

After cavernosal injection of microbubbles no adverse events were observed. Contrast enhanced US showed unilateral enhancement of the corpus cavernosum in which microbubbles were injected. Cavernosography confirmed unilateral corporeal opacification.

Conclusion

Contrast enhanced US can be used effectively to diagnose complete penile corporeal septation.
Literature
1.
go back to reference Kolbenstveldt A, Egge T, Klevmark B, et al. (1990) Isolated cavernous bodies. J Urol 143:256–257 Kolbenstveldt A, Egge T, Klevmark B, et al. (1990) Isolated cavernous bodies. J Urol 143:256–257
2.
go back to reference Montague DK, Lakin MM, Angermeier KW, et al. (1995) Primary erectile dysfunction in a man with congenital isolation of the corpora cavernosa. Urology 46:114–116PubMedCrossRef Montague DK, Lakin MM, Angermeier KW, et al. (1995) Primary erectile dysfunction in a man with congenital isolation of the corpora cavernosa. Urology 46:114–116PubMedCrossRef
4.
go back to reference Matter LE, Hailemariam LE, Huch RA, et al. (1998) Primary erectile dysfunction in combination with congenital malformation of the cavernous bodies. Urol Int 60:175–177PubMedCrossRef Matter LE, Hailemariam LE, Huch RA, et al. (1998) Primary erectile dysfunction in combination with congenital malformation of the cavernous bodies. Urol Int 60:175–177PubMedCrossRef
5.
go back to reference Blomley MJK, Cooke JC, Unger EC, et al. (2002) Microbubble contrast agents: a new era in ultrasound. BMJ 322:1222–1225CrossRef Blomley MJK, Cooke JC, Unger EC, et al. (2002) Microbubble contrast agents: a new era in ultrasound. BMJ 322:1222–1225CrossRef
6.
go back to reference Morel DR, Schwieger I, Hohn L, et al. (2000) Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35:80–85PubMedCrossRef Morel DR, Schwieger I, Hohn L, et al. (2000) Human pharmacokinetics and safety evaluation of SonoVue, a new contrast agent for ultrasound imaging. Invest Radiol 35:80–85PubMedCrossRef
7.
go back to reference Cosgrove D (2004) Future prospects for SonoVue and CPS. Eur Radiol 14(suppl 8):P116–P124PubMed Cosgrove D (2004) Future prospects for SonoVue and CPS. Eur Radiol 14(suppl 8):P116–P124PubMed
8.
go back to reference Karademiz T, Topsakal M, Ariman A, et al. (1996) Penile fracture: differential diagnosis, management and outcome. Br J Urol 77:279–281 Karademiz T, Topsakal M, Ariman A, et al. (1996) Penile fracture: differential diagnosis, management and outcome. Br J Urol 77:279–281
Metadata
Title
Complete penile corporeal septation: evaluation with contrast enhanced US
Authors
Michele Bertolotto
Stefano Bucci
Emilio Quaia
Matteo Coss
Giovanni Liguori
Publication date
01-09-2008
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 5/2008
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-008-9400-z

Other articles of this Issue 5/2008

Abdominal Radiology 5/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.